John G. Clawson

Keine laufenden Positionen mehr

96 Jahre

Consumer Services

Finance

Distribution Services

Profil

John G.
Clawson served as the Chief Executive Officer of Hill-Rom, Inc. from 1975 to 1993.
He was also the Director of Non-Invasive Monitoring Systems, Inc. from 2002 to 2008.
Clawson served as an Independent Director of Endocyte, Inc. from 2011 to 2012.
He holds an MBA from Harvard University and an undergraduate degree from Brigham Young University.

Ehemalige bekannte Positionen von John G. Clawson

Unternehmen	Position	Ende
ENDOCYTE, INC.	Vorsitzender	18.07.2011
NON-INVASIVE MONITORING SYSTEMS, INC.	Direktor/Vorstandsmitglied	03.11.2008
Hill-Rom, Inc. Hill-Rom, Inc. Medical DistributorsDistribution Services Hill-Rom, Inc. provides medical equipment and services. The company was founded on October 23, 1929 and is headquartered in Batesville, IN.	Präsident	01.01.1993

Sehen Sie sich die Erfahrung von John G. Clawson im Detail an

Ausbildung von John G. Clawson

Brigham Young University	Undergraduate Degree
Harvard University	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von John G. Clawson im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
NON-INVASIVE MONITORING SYSTEMS, INC.	Finance

Private Unternehmen	2
Hill-Rom, Inc. Hill-Rom, Inc. Medical DistributorsDistribution Services Hill-Rom, Inc. provides medical equipment and services. The company was founded on October 23, 1929 and is headquartered in Batesville, IN.	Distribution Services
Endocyte, Inc. Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.	Health Technology